Raymond James & Associates’s Healthcare Realty HR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.06M | Sell |
58,171
-136,601
| -70% | -$2.42M | ﹤0.01% | 2655 |
|
|
2024
Q2 | $3.21M | Sell |
194,772
-342,347
| -64% | -$5.24M | ﹤0.01% | 1876 |
|
|
2024
Q1 | $7.6M | Sell |
537,119
-315,422
| -37% | -$4.76M | 0.01% | 1312 |
|
|
2023
Q4 | $14.7M | Sell |
852,541
-92,948
| -10% | -$1.42M | 0.01% | 877 |
|
|
2023
Q3 | $14.4M | Buy |
945,489
+30,349
| +3% | +$539K | 0.01% | 832 |
|
|
2023
Q2 | $17.3M | Sell |
915,140
-12,275
| -1% | -$237K | 0.01% | 775 |
|
|
2023
Q1 | $17.9M | Sell |
927,415
-13,458
| -1% | -$271K | 0.02% | 732 |
|
|
2022
Q4 | $18.1M | Buy |
940,873
+93,320
| +11% | +$1.83M | 0.02% | 714 |
|
|
2022
Q3 | $17.7M | Buy |
847,553
+786,965
| +1,299% | +$20M | 0.02% | 661 |
|
|
2022
Q2 | $1.69M | Sell |
60,588
-176
| -0.3% | -$5.23K | ﹤0.01% | 2091 |
|
|
2022
Q1 | $1.9M | Buy |
60,764
+5,307
| +10% | +$167K | ﹤0.01% | 2163 |
|
|
2021
Q4 | $1.85M | Sell |
55,457
-6,090
| -10% | -$203K | ﹤0.01% | 2233 |
|
|
2021
Q3 | $1.82M | Sell |
61,547
-507
| -0.8% | -$14.8K | ﹤0.01% | 2170 |
|
|
2021
Q2 | $1.66M | Buy |
62,054
+7,793
| +14% | +$220K | ﹤0.01% | 2234 |
|
|
2021
Q1 | $1.5M | Sell |
54,261
-16,069
| -23% | -$449K | ﹤0.01% | 2227 |
|
|
2020
Q4 | $1.94M | Sell |
70,330
-23,103
| -25% | -$610K | ﹤0.01% | 1908 |
|
|
2020
Q3 | $2.43M | Buy |
93,433
+55,264
| +145% | +$1.45M | ﹤0.01% | 1630 |
|
|
2020
Q2 | $1.01M | Buy |
38,169
+3,588
| +10% | +$91.9K | ﹤0.01% | 2157 |
|
|
2020
Q1 | $840K | Sell |
34,581
-10,603
| -23% | -$320K | ﹤0.01% | 2099 |
|
|
2019
Q4 | $1.37M | Buy |
45,184
+4,292
| +10% | +$128K | ﹤0.01% | 2074 |
|
|
2019
Q3 | $1.2M | Buy |
40,892
+2,224
| +6% | +$62.2K | ﹤0.01% | 2085 |
|
|
2019
Q2 | $1.06M | Sell |
38,668
-5,088
| -12% | -$143K | ﹤0.01% | 2175 |
|
|
2019
Q1 | $1.25M | Sell |
43,756
-241,588
| -85% | -$6.72M | ﹤0.01% | 2064 |
|
|
2018
Q4 | $7.22M | Sell |
285,344
-25,479
| -8% | -$675K | 0.01% | 917 |
|
|
2018
Q3 | $8.29M | Buy |
310,823
+1,612
| +0.5% | +$44.4K | 0.01% | 940 |
|
|
2018
Q2 | $8.34M | Sell |
309,211
-637,637
| -67% | -$16.2M | 0.01% | 914 |
|
|
2018
Q1 | $25M | Buy |
946,848
+113,302
| +14% | +$3.02M | 0.04% | 394 |
|
|
2017
Q4 | $25M | Buy |
833,546
+93,975
| +13% | +$2.84M | 0.05% | 388 |
|
|
2017
Q3 | $22M | Buy |
739,571
+462,887
| +167% | +$14.1M | 0.04% | 413 |
|
|
2017
Q2 | $8.61M | Buy |
276,684
+258,612
| +1,431% | +$8.15M | 0.02% | 777 |
|
|
2017
Q1 | $569K | Buy |
18,072
+2,265
| +14% | +$68.7K | ﹤0.01% | 2301 |
|
|
2016
Q4 | $460K | Buy |
15,807
+1,209
| +8% | +$35.6K | ﹤0.01% | 2388 |
|
|
2016
Q3 | $476K | Sell |
14,598
-761
| -5% | -$25.2K | ﹤0.01% | 2320 |
|
|
2016
Q2 | $497K | Sell |
15,359
-8,103
| -35% | -$244K | ﹤0.01% | 2111 |
|
|
2016
Q1 | $690K | Sell |
23,462
-18,389
| -44% | -$510K | ﹤0.01% | 1872 |
|
|
2015
Q4 | $1.13M | Buy |
41,851
+6,715
| +19% | +$173K | ﹤0.01% | 1575 |
|
|
2015
Q3 | $861K | Sell |
35,136
-3,430
| -9% | -$84.6K | ﹤0.01% | 1669 |
|
|
2015
Q2 | $924K | Sell |
38,566
-817
| -2% | -$20.9K | ﹤0.01% | 1780 |
|
|
2015
Q1 | $1.1M | Sell |
39,383
-14,148
| -26% | -$398K | ﹤0.01% | 1611 |
|
|
2014
Q4 | $1.44M | Buy |
53,531
+23,950
| +81% | +$606K | 0.01% | 1338 |
|
|
2014
Q3 | $686K | Buy |
29,581
+18,558
| +168% | +$450K | ﹤0.01% | 1716 |
|
|
2014
Q2 | $265K | Buy |
+11,023
| New | +$263K | ﹤0.01% | 2085 |
|
Other funds holding HR
RIM
AAMU
Raymond James & Associates's HR Position: Q3 2024 in Review
Raymond James & Associates reduced its Healthcare Realty (HR) stake by 70% in Q3 2024, selling an estimated $2.42M and leaving 58,171 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2655.
Raymond James & Associates first reported a position in HR in Q2 2014 and has held it in 42 quarters since. The position peaked at $25M in Q1 2018. 410 funds tracked by Wall St. Rank hold HR as of Q3 2024.
- Raymond James & Associates held 58,171 shares of Healthcare Realty worth $1.06M as of Q3 2024.
- Raymond James & Associates sold 136,601 Healthcare Realty shares in Q3 2024, an estimated $2.42M.
- Healthcare Realty made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2655 holding.
- Raymond James & Associates first reported a position in Healthcare Realty in Q2 2014 and has held it in 42 quarters since.
- Raymond James & Associates's Healthcare Realty position peaked at $25M in Q1 2018.
- 410 funds tracked by Wall St. Rank held Healthcare Realty as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.